News

A team led by Professor Toni Cathomen at the University of Freiburg (Germany) has secured £1M of CRACK IT Challenge funding to develop an approach to evaluate the tumourigenicity of human engineered T cell therapies. 

Sponsor a Challenge: overcome scientific barriers with 3Rs-driven solutions. We are looking for stakeholders from across the biosciences to submit their ideas for new CRACK IT Challenges.

We are looking for experts with research questions that could be solved with a 3Rs driven approach.

The 2023 CRACK IT Challenges Competition is now open - Invitation to Tender

Open for applications: four new Challenges have been announced in this year’s open innovation funding competition.

Funding for 18 months has been awarded to a team at KREATiS to deliver the CRACK IT Challenge Thyroid Tox.

esqLABS have been awarded the Phase 2 contract to develop a NAMs-driven in silico framework to predict toxicological endpoints in the dog.

19 January 2023

Two teams have been awarded £100k funding each to carry out Phase 1 proof-of-concept studies to establish an in vitro assay system to evaluate the tumourigenicity of genetically engineered T cell therapies*.